24 July 2025
InnoStrat has secured funding from Denmark’s Export and Investment Fund (EIFO) to expand its consulting capabilities and global reach within the life science sector.
The EIFO funding will enable InnoStrat to enhance its service offerings and increase capacity to support pharmaceutical and medical device companies worldwide as they navigate increasingly complex clinical, medical, and commercial challenges.
Strengthening Global Life Science Innovation
Founded by industry veterans with deep expertise in major pharmaceutical and medical device companies, InnoStrat specializes in the human aspect of business transformation. The company helps life science organizations implement strategies that turn complex clinical and medical challenges into lean, cost-effective solutions.
“This funding represents a significant milestone in our mission to empower business transformation in life science companies globally,” said Jan Kildeskov, Co-Founder. “With EIFO’s support, we can expand our capacity to help more organizations improve trial enrollment rates, create better integrated evidence-generation plans, and maximize the value of their real-world evidence.“
Enhanced Capabilities for Industry Challenges
The expanded capabilities will focus on several key areas critical to modern life science companies:
Clinical Development Excellence: Enhanced support for streamlining clinical trial processes, improving enrollment strategies, and optimizing study designs to accelerate time-to-market for innovative therapies.
Medical Affairs Transformation: Strengthened expertise in elevating Medical Affairs capabilities to big pharma standards, helping organizations bridge external stakeholder needs with internal R&D and commercial functions.
Commercial Innovation: Expanded capacity to support go-to-market strategies, evidence-based product positioning, and commercial transformation initiatives.
Digital Health & AI Integration: Enhanced resources to help companies leverage digital technologies and artificial intelligence to improve patient outcomes and operational efficiency.
Supporting Industry Growth
The life science industry continues to face mounting pressure to deliver innovative treatments more efficiently while navigating regulatory complexity and market access challenges. InnoStrat’s expanded capabilities address these industry-wide needs by providing agile consulting solutions that deliver measurable impact.
“Our approach has always been about understanding that successful transformation requires focusing on people as much as processes,” added Mikkel Nielsen, Co-Founder. “This funding allows us to scale that human-centered approach to help more life science companies achieve their strategic objectives.“
About EIFO
Denmark’s Export and Investment Fund (EIFO) provides financial solutions to Danish companies looking to expand internationally. With a focus on sustainable growth and innovation, EIFO offers a range of financing and advisory services to support Danish businesses in their global expansion efforts.
Media Contact: Jan Kildeskov
InnoStrat
Phone: +45 2445 3424
